Thyroid cancer
Conditions
Interventions
Intervention period: 1 day During surgery, 25 mg of ICG is diluted to 5 to 10 ml of water for injection, 0.04 to 0.3 mg / kg is intravenously administered, and then observation is performed using a n
Sponsors
Kobe University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Consent Acceptance of documents by voluntary free will at the age of over 20 years at the time of acquisition. 2. Histologically or clinically diagnosed as thyroid cancer. 3.Thyroid lobectomy or total thyroidectomy is planned for thyroid tumor. 4. It is the first treatment example for thyroid tumor.
Exclusion criteria
Exclusion criteria: 1.There is a history of hypersensitivity in the ICG preparation. 2.Have clear iodine allergy. 3.Thyroid cancer suspected of parathyroid invasion clinically or imagewise. 4.Other patients judged inappropriate by the doctor in charge of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Availability of blood flow imaging of parathyroid tissue using ICG fluorescence in surgery for thyroid cancer | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the fluorescence concentration of parathyroid tissue visualized by ICG fluorescence method with that of the surrounding tissue and to measure the concentration ratio, in standard surgery (total thyroidectomy or Flocculus resection) | — |
Countries
Japan
Contacts
Public ContactKeisuke Iritani
Kobe University Hospital Otorhinolaryngology, head and neck surgery
Outcome results
None listed